45 related articles for article (PubMed ID: 38561454)
21. HIF-1α pathway: role, regulation and intervention for cancer therapy.
Masoud GN; Li W
Acta Pharm Sin B; 2015 Sep; 5(5):378-89. PubMed ID: 26579469
[TBL] [Abstract][Full Text] [Related]
22. Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells.
Wang Y; Liu Y; Tang F; Bernot KM; Schore R; Marcucci G; Caligiuri MA; Zheng P; Liu Y
Blood; 2014 Aug; 124(7):1127-35. PubMed ID: 24994068
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of quinaldopeptin.
Katayama K; Okamura T; Sunadome T; Nakagawa K; Takeda H; Shiro M; Matsuda A; Ichikawa S
J Org Chem; 2014 Mar; 79(6):2580-90. PubMed ID: 24555872
[TBL] [Abstract][Full Text] [Related]
24. Total synthesis of sandramycin and its analogues via a multicomponent assemblage.
Katayama K; Nakagawa K; Takeda H; Matsuda A; Ichikawa S
Org Lett; 2014 Jan; 16(2):428-31. PubMed ID: 24341513
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of minimalist terminal alkyne-containing diazirine photo-crosslinkers and their incorporation into kinase inhibitors for cell- and tissue-based proteome profiling.
Li Z; Hao P; Li L; Tan CY; Cheng X; Chen GY; Sze SK; Shen HM; Yao SQ
Angew Chem Int Ed Engl; 2013 Aug; 52(33):8551-6. PubMed ID: 23754342
[No Abstract] [Full Text] [Related]
26. Recent developments in bisintercalator natural products.
Zolova OE; Mady AS; Garneau-Tsodikova S
Biopolymers; 2010 Sep; 93(9):777-90. PubMed ID: 20578002
[TBL] [Abstract][Full Text] [Related]
27. Bisintercalator natural products with potential therapeutic applications: isolation, structure determination, synthetic and biological studies.
Dawson S; Malkinson JP; Paumier D; Searcey M
Nat Prod Rep; 2007 Feb; 24(1):109-26. PubMed ID: 17268609
[TBL] [Abstract][Full Text] [Related]
28. Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.
Kong D; Park EJ; Stephen AG; Calvani M; Cardellina JH; Monks A; Fisher RJ; Shoemaker RH; Melillo G
Cancer Res; 2005 Oct; 65(19):9047-55. PubMed ID: 16204079
[TBL] [Abstract][Full Text] [Related]
29. SW-163C and E, novel antitumor depsipeptides produced by Streptomyces sp. II. Structure elucidation.
Takahashi K; Koshino H; Esumi Y; Tsuda E; Kurosawa K
J Antibiot (Tokyo); 2001 Aug; 54(8):622-7. PubMed ID: 11592498
[TBL] [Abstract][Full Text] [Related]
30. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
[TBL] [Abstract][Full Text] [Related]
31. Thiocoraline, a new depsipeptide with antitumor activity produced by a marine Micromonospora. I. Taxonomy, fermentation, isolation, and biological activities.
Romero F; Espliego F; Pérez Baz J; García de Quesada T; Grávalos D; de la Calle F; Fernández-Puentes JL
J Antibiot (Tokyo); 1997 Sep; 50(9):734-7. PubMed ID: 9360617
[TBL] [Abstract][Full Text] [Related]
32. A phase II clinical trial of echinomycin in metastatic soft tissue sarcoma. An Illinois Cancer Center Study.
Gradishar WJ; Vogelzang NJ; Kilton LJ; Leibach SJ; Rademaker AW; French S; Benson AB
Invest New Drugs; 1995; 13(2):171-4. PubMed ID: 8617582
[TBL] [Abstract][Full Text] [Related]
33. Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies. A Southwest Oncology Group study.
Taylor SA; Crowley J; Townsend J; Vogel FS; Eyre H; Braun JJ; Goodwin JW
J Neurooncol; 1993 Feb; 15(2):181-4. PubMed ID: 8509822
[TBL] [Abstract][Full Text] [Related]
34. Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study.
Marshall ME; Wolf MK; Crawford ED; Taylor S; Blumenstein B; Flanigan R; Meyers FJ; Hynes HE; Barlogie B; Eisenberger M
Invest New Drugs; 1993; 11(2-3):207-9. PubMed ID: 8262733
[TBL] [Abstract][Full Text] [Related]
35. Echinomycin in recurrent and metastatic endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Blessing JA; DuBeshter B
Am J Clin Oncol; 1993 Dec; 16(6):492-3. PubMed ID: 8256763
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer.
Wadler S; Tenteromano L; Cazenave L; Sparano JA; Greenwald ES; Rozenblit A; Kaleya R; Wiernik PH
Cancer Chemother Pharmacol; 1994; 34(3):266-9. PubMed ID: 8004762
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study.
Shevrin DH; Lad TE; Guinan P; Kilton LJ; Greenburg A; Johnson P; Blough RR; Hoyer H
Invest New Drugs; 1994; 12(1):65-6. PubMed ID: 7960609
[No Abstract] [Full Text] [Related]
38. Phase II study of echinomycin in the treatment of renal cell carcinoma ECOG study E2885.
Chang AY; Tu ZN; Bryan GT; Kirkwood JM; Oken MM; Trump DL
Invest New Drugs; 1994; 12(2):151-3. PubMed ID: 7860234
[TBL] [Abstract][Full Text] [Related]
39. Echinomycin: a bifunctional intercalating antibiotic.
Waring MJ; Wakelin LP
Nature; 1974 Dec; 252(5485):653-7. PubMed ID: 4437614
[No Abstract] [Full Text] [Related]
40. A comparison of the structure of echinomycin and triostin A complexed to a DNA fragment.
Ughetto G; Wang AH; Quigley GJ; van der Marel GA; van Boom JH; Rich A
Nucleic Acids Res; 1985 Apr; 13(7):2305-23. PubMed ID: 4000957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
